[HTML][HTML] Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis

…, J New‐Tolley, M Powell, A Quinlivan… - The Cochrane …, 2020 - ncbi.nlm.nih.gov
… New‐Tolley, Maria Powell, Alannah Quinlivan, Amro Qaddoura, Rob Deardon, … Alannah
Quinlivan: pilot‐tested data collection and quality assessment, … Alannah Quinlivan: None known …

Gastrointestinal tract considerations: part II: how should a rheumatologist best manage common lower gastrointestinal tract complaints in systemic sclerosis?

A Quinlivan, ZH McMahan, EB Lee… - Rheumatic Disease …, 2023 - rheumatic.theclinics.com
Systemic sclerosis (SSc; ie, scleroderma) is an autoimmune connective tissue with pathogenic
features of autoimmunity, inflammation, vasculopathy, and/or fibrosis of the skin and …

Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars

A Quinlivan, S Lester, C Barrett, S Whittle… - … Advances in Practice, 2022 - academic.oup.com
Objectives To investigate the knowledge and beliefs of Australian patients with inflammatory
arthritis regarding biologic/targeted synthetic DMARDs (b/tsDMARDs) and biosimilars and …

Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia

…, A Rischin, A Scott-Charlton, A Quinlivan… - JAMA Network …, 2023 - jamanetwork.com
Importance There is a need for observational studies to supplement evidence from clinical
trials, and the target trial emulation (TTE) framework can help avoid biases that can be …

The effects of Red Bull energy drink compared with caffeine on cycling time-trial performance

A Quinlivan, C Irwin, GD Grant… - … journal of sports …, 2015 - journals.humankinetics.com
This study investigated the ergogenic effects of a commercial energy drink (Red Bull) or an
equivalent dose of anhydrous caffeine in comparison with a noncaffeinated control beverage …

[HTML][HTML] Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions

T Khoo, N Sidhu, F Marine, S Lester, A Quinlivan… - BMC rheumatology, 2022 - Springer
Background Biologic and targeted synthetic disease modifying agents (b/tsDMARDs) have
broadened the treatment landscape for autoimmune diseases particularly in patients …

Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis

A Quinlivan, V Thakkar, W Stevens… - Internal medicine …, 2015 - Wiley Online Library
Background Screening for pulmonary arterial hypertension ( PAH ) in systemic sclerosis (
SSc ) is now standard care in this disease. The existing A ustralian S cleroderma I nterest G …

Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: a systematic review and meta-analysis

JL Fairley, L Ross, A Quinlivan, D Hansen… - Seminars in Arthritis and …, 2023 - Elsevier
Objective To calculate the frequency of sudden cardiac death(SCD), arrhythmia and conduction
defects in SSc. Methods MEDLINE/EMBASE were searched to January 2023. English-…

Vaccination rates, perceptions, and information sources used by people with inflammatory arthritis

A Lyon, A Quinlivan, S Lester, C Barrett… - ACR Open …, 2023 - Wiley Online Library
Objective To determine vaccination rates, perceptions, and information sources in people
with inflammatory arthritis. Methods Participants enrolled in the Australian Rheumatology …

[HTML][HTML] Eosinophilic vasculitis and arteritic anterior ischemic optic neuropathy associated with anti-PD-L1 therapy

EC Berry, S Mullany, A Quinlivan, A Craig… - Journal of …, 2022 - journals.lww.com
Immune checkpoint inhibitor therapy is frequently associated with immune-related adverse
events, which occasionally manifest with visual symptoms. Here, we describe a case of …